NOVOSTE AND BEST VASCULAR
Krish Suthanthiran, President of Best Vascular, has commented, "We are very excited about the opportunity that exists for Best Vascular in the VBT market. The acquisition of these assets fits our strategy of providing brachytherapy products across a wide variety of clinical applications. It is of utmost importance that radiation therapy is available to cardiologists and their patients. The Novoste system is the only remaining vascular brachytherapy product on the market and having previously supplied Cordis Corporation, a Johnson & Johnson company with VBT products, we believe we have the capability to assure the continuation of this important therapy in the cardiology market. We remain committed to our radiation oncology customer base and look forward to serving the particular needs of the cardiology community with a therapy that has proven to have durable results..."
Best Vascular intends to formally launch its marketing of the Novoste, BetaCath product at a special breakfast symposium on Wednesday, April 5, 2006 beginning at 7:00 a.m. The symposium will be held at the Hyatt Regency Crystal City in Arlington, Virginia in conjunction with the Cardiovascular Revascularization Therapies (CRT) meeting. Sponsored by Best Vascular, the breakfast symposium will update the status of vascular brachytherapy and the BetaCath of Novoste for 2006 and will feature presentations on the treatment of drug-eluting stent restenosis with vascular brachytherapy and five-year clinical follow-up data with the BetaCath system. In addition, discussions on new opportunities for your institution to re-launch the BetaCath system will also take place.
Al Novak, President and Chief Executive Officer of Novoste, said "We are pleased that we have completed this transaction with Best Vascular. They have the capability and interest in supplying VBT to those physicians and their patients who have a need for this technology. This transaction was in the best interests of our shareholders by allowing Novoste to be free of its major liabilities associated with the VBT business."
About Best Vascular and Best Medical International, Inc.
About Novoste (now known as NOVT Corporation)